1 completed, 1 unknown, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
Follow Low-dose Radiotherapy: new trials by email Literature Review of Low-dose Radiotherapy trials Research Report on Low-dose Radiotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients. Tislelizumab, Afatinib, Low dose radiotherapy - Head and Neck Squamous Cell Carcinoma, Low-dose Radiotherapy | Phase 2 | Completed | West China Hospital | 98 | 2025-06-28 | 2026-06-30 |
| Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy low dose radiotherapy - Low-dose Radiotherapy, Tumor Microenvironment | Phase 2 | Withdrawn | Hetian District People's Hospital | 2024-03-18 | 2024-04-25 | |
| Low-dose Radiotherapy in iNHL Low-dose radiotherapy - Indolent Lymphoma, Low-dose Radiotherapy | Phase 2 | Unknown | Chinese Academy of Medical Sciences | 73 | 2022-05-01 | 2022-09-16 |
Carcinoma, Non-Small-Cell Lung (1) · Squamous Cell Carcinoma of Head and Neck (1)
Neoplasms (2) · Neoplasms by Site (2) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Radiotherapy (3) · Afatinib (1) · Immunotherapy (1) · tislelizumab (1)
Chinese Academy of Medical Sciences (1) · Hetian District People's Hospital (1) · West China Hospital (1)
China (3)